Collaborative Efforts Under Way To Combat Malaria

Sidebars Malaria: A Statistical Index Funding Agencies For Malaria Research Researchers in the field lament what they call gross underfunding, but say a joint approach will help ensure that avaliable monies are well spent. After several years of declining interest in malaria research and decreasing support for such studies, the field is gaining much-needed momentum. Spurred in part by an international conference held in Dakar, Senegal, in January, funding agencies and scientists around the gl

Written byAlison Mack
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


Researchers in the field lament what they call gross underfunding, but say a joint approach will help ensure that avaliable monies are well spent.
After several years of declining interest in malaria research and decreasing support for such studies, the field is gaining much-needed momentum. Spurred in part by an international conference held in Dakar, Senegal, in January, funding agencies and scientists around the globe are planning unprecedented cooperative research and development programs to combat the disease.

Each year, malaria kills between 1.5 million and 2.7 million people-mainly children younger than five years of age-according to the World Health Organization (WHO). An estimated 300 million to 500 million clinical cases of the disease occur annually, of which about 90 percent appear in sub-Saharan Africa.

CHICKEN OR EGG: Countries too poor to control malaria suffer more economic losses as workers become ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies